PERRIGO Co plc (PRGO)
Health Care / Pharmaceuticals
S&P SmallCap 600$11.00
Scores poorly across most models. Proceed with caution.
Avoid
Score based on 4 of 5 models — moderate confidence
Is PERRIGO Co plc a Good Investment in 2026?
PERRIGO Co plc (PRGO) scores 1.5 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Piotroski model is the most favorable, rating PERRIGO Co plc as Neutral. However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 92%). PERRIGO Co plc currently trades below its estimated fair value of $17, suggesting potential upside. PERRIGO Co plc ranks #1108 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Fair value above market price — fundamentals support a higher valuation.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Neutral
4/9
Buffett
Caution
Business quality & competitive moat
Graham
Neutral
Price vs intrinsic value
Lynch
Neutral
Growth rate vs price (PEG)
Greenblatt
Caution
Bottom half (rank 92%)
Frequently Asked Questions
Is PERRIGO Co plc (PRGO) a good investment?
What is PERRIGO Co plc's Piotroski F-Score?
Is PRGO overvalued or undervalued?
How does PRGO compare to other Health Care stocks?
What do investment models say about PRGO?
Similar Stocks
Compare PRGO with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer